Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease
Obesity and steatosis have been associated with liver disease progression in patients with compensated advanced chronic liver disease (cACLD) (liver stiffness measurement [LSM] ≥ 10 kPa). The controlled attenuation parameter (CAP) estimates steatosis during LSM by transient elastography. We aimed to...
Main Authors: | Cristina Margini, Giuseppe Murgia, Guido Stirnimann, Andrea De Gottardi, Nasser Semmo, Stefania Casu, Jaime Bosch, Jean‐François Dufour, Annalisa Berzigotti |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-08-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1201 |
Similar Items
-
Hepatic manifestations of drug reaction with eosinophilia and systemic symptoms syndrome
by: Maria Gabriela Delgado, et al.
Published: (2021-04-01) -
Non-Invasive Diagnostic and Prognostic Evaluation of Liver Cirrhosis and Portal Hypertension
by: Annalisa Berzigotti, et al.
Published: (2011-01-01) -
Nutritional Challenges in Patients with Advanced Liver Cirrhosis
by: Jessica Stirnimann, et al.
Published: (2019-11-01) -
Effect of meal ingestion on liver stiffness in patients with cirrhosis and portal hypertension.
by: Annalisa Berzigotti, et al.
Published: (2013-01-01) -
Advances and challenges in cirrhosis and portal hypertension
by: Annalisa Berzigotti
Published: (2017-11-01)